Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists

被引:39
作者
Witherington, J
Bordas, V
Cooper, DG
Forbes, IT
Gribble, AD
Ife, RJ
Berkhout, T
Gohil, J
Groot, PHE
机构
[1] GlaxoSmithKline Pharmaceut, Dept Discovery Chem, Harlow CM19 5AD, Essex, England
[2] GlaxoSmithKline Pharmaceut, Dept Vasc Biol, Harlow CM19 5AD, Essex, England
关键词
D O I
10.1016/S0960-894X(01)00397-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The preparation and biological evaluation of a series of indolopiperidine CCR2B receptor antagonists possessing a conformationally restricted C-5 linker chain in combination with a restricted piperidine ring are described. Compared to the parent compound 1, analogue 8 shows a dramatic improvement in selectivity against a range of 5-HT and dopaminergic receptors. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2177 / 2180
页数:4
相关论文
共 9 条
  • [1] Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
    Boring, L
    Gosling, J
    Cleary, M
    Charo, IF
    [J]. NATURE, 1998, 394 (6696) : 894 - 897
  • [2] MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS
    CHARO, IF
    MYERS, SJ
    HERMAN, A
    FRANCI, C
    CONNOLLY, AJ
    COUGHLIN, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2752 - 2756
  • [3] CCR2B receptor antagonists: Conversion of a weak HTS hit to a potent lead compound
    Forbes, IT
    Cooper, DG
    Dodds, EK
    Hickey, DMB
    Ife, RJ
    Meeson, M
    Stockley, M
    Berkhout, TA
    Gohil, J
    Groot, PHE
    Moores, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (16) : 1803 - 1806
  • [4] Highly stereoselective synthesis of exo and endo indolotropanes
    Forbes, IT
    [J]. TETRAHEDRON LETTERS, 1999, 40 (52) : 9293 - 9295
  • [5] An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model
    Gong, JH
    Ratkay, LG
    Waterfield, JD
    ClarkLewis, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 131 - 137
  • [6] MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
    Gosling, J
    Slaymaker, S
    Gu, L
    Tseng, S
    Zlot, CH
    Young, SG
    Rollins, BJ
    Charo, IF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) : 773 - 778
  • [7] LEONARD EJ, 1994, CHALL MOD MED, V3, P25
  • [8] Monocyte chemoattractant protein 1 a potential regulator of monocyte recruitment in inflammatory disease
    Rollins, BJ
    [J]. MOLECULAR MEDICINE TODAY, 1996, 2 (05): : 198 - 204
  • [9] Opportunities for novel therapeutic agents acting at chemokine receptors
    Saunders, J
    Tarby, CM
    [J]. DRUG DISCOVERY TODAY, 1999, 4 (02) : 80 - 92